EDP Sciences logo
Open Access
Ann Toxicol Anal
Volume 22, Numéro 2, 2010
Page(s) 69 - 74
DOI https://doi.org/10.1051/ata/2010012
Publié en ligne 26 mai 2010
  1. Labat L, Deveaux M. Immunoanalyse et toxicologie. Ann Toxicol Anal. 2009; 21(1): 1-2. [CrossRef] [EDP Sciences] [Google Scholar]
  2. Hand C, Baldwin D. Immunoassays. In : Moffat C (coordinateur) Clarke’s analysis of drugs and poisons, third edition. London : Pharmaceutical press 2004: 301-312. [Google Scholar]
  3. Slightom EL, McCurdy HH. Enzyme immunoassay: novel approaches to tissue and fluid analysis. In : Baselt RC (coordinateur) Advances in analytical toxicology, vol 1. Foster city : Biomedical publications 1984: 9-40. [Google Scholar]
  4. Peel HW, Perrigo BJ. Detection of cannabinoids in blood using EMIT. J Anal Toxicol. 1981; 5(4): 165-167. [PubMed] [Google Scholar]
  5. Asselin WM, Leslie JM, McKinley B. Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays. J Anal Toxicol. 1988; 12(4): 207-215. [CrossRef] [PubMed] [Google Scholar]
  6. Lewellen LJ, McCurdy HH. A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT). J Anal Toxicol. 1988; 12(5): 260-264. [CrossRef] [PubMed] [Google Scholar]
  7. Bogusz M, Aderjan R, Schmitt G, Nadler E, Neureither B. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays – a comparative study. Forensic Sci Int. 1990, 48(1): 27-37. [CrossRef] [PubMed] [Google Scholar]
  8. Cagle JC, McCurdy HH, Pan YM, Ayton KJ, Wall WH, Solomons ET. Evaluation of the CEDIA DAU assays and the AxSym system for the analysis of cannabinoids in whole blood. J Anal Toxicol. 1997; 21(3): 213-217. [CrossRef] [PubMed] [Google Scholar]
  9. McCord CE, McCutcheon JR. Preliminary evaluation of the Abbott TDx for benzoylecgonine and opiate screening in whole blood. J Anal Toxicol. 1988; 12(5): 295-297. [PubMed] [Google Scholar]
  10. Klinger RA, Blum LM, Rieders F. Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma, and postmortem blood for amphetamines, barbiturates, methadone, methaqualone, phencyclidine, and propoxyphene. J Anal Toxicol. 1990; 14(5): 288-291. [PubMed] [Google Scholar]
  11. Simonick TF, Watts VW. Preliminary evaluation of the Abbott TDx for screening of D-methamphetamine in whole blood specimens. J Anal Toxicol. 1992; 16(2): 115-118. [PubMed] [Google Scholar]
  12. Slightom EL. The analysis of drugs in blood, bile, and tissue with an indirect homogeneous enzyme immunoassay. J Forensic Sci. 1978; 23(2): 292-303. [PubMed] [Google Scholar]
  13. Huang W, Moody DE. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood. J Anal Toxicol. 1995; 19(6): 333-342. [PubMed] [Google Scholar]
  14. Lee CW, Lee HM. Evaluation of the Abbott TDx analyzer. J Anal Toxicol. 1989; 13(1): 50-56. [PubMed] [Google Scholar]
  15. Iwersen-Bergmann S, Schmoldt A. Direct semiquantitative screening of drugs of abuse in serum and whole blood by means of CEDIA DAU urine immunoassays. J Anal Toxicol. 1999; 23(4): 247-256. [CrossRef] [PubMed] [Google Scholar]
  16. Hino Y, Ojanperä I, Rasanen I, Vuori E. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic Sci Int. 2003; 131(2-3): 148-155. [CrossRef] [PubMed] [Google Scholar]
  17. Lillsunde P, Michelson L, Forsstrom T, Korte T, Schultz E, Ariniemi K, Portman M, Sihvonen ML, Seppala T. Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety. Forensic Sci Int. 1996; 77(3): 191-210. [CrossRef] [PubMed] [Google Scholar]
  18. Kroener L, Musshoff F, Madea B. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD. J Anal Toxicol. 2003; 27(4): 205-212. [CrossRef] [PubMed] [Google Scholar]
  19. Spiehler V. Hair analysis by immunological methods from the beginning to 2000. Forensic Sci Int. 2000; 107(1-3): 249-259. [CrossRef] [PubMed] [Google Scholar]
  20. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol. 2008; 32(6): 393-401. [CrossRef] [PubMed] [Google Scholar]
  21. Lin DL, Chen CY, Shaw KP, Havier R, Lin RL. Distribution of codeine, morphine, and 6-acetylmorphine in vitreous humor. J Anal Toxicol. 1997; 21(4): 258-261. [PubMed] [Google Scholar]
  22. Chronister CW, Walrath JC, Goldberger BA. Rapid detection of benzoylecgonine in vitreous humor by enzyme immunoassay. J Anal Toxicol. 2001; 25(7): 621-624. [PubMed] [Google Scholar]
  23. Chronister CW, Gund AL, Goldberger BA. Rapid detection of opioids in vitreous humor by enzyme immunoassay. J Anal Toxicol. 2008; 32(8): 601-604. [PubMed] [Google Scholar]
  24. Fucci N, De Giovanni N, De Giorgio F, Liddi R, Chiarotti M. An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor. Forensic Sci Int. 2006; 156(2-3): 102-105. [CrossRef] [PubMed] [Google Scholar]
  25. Moore KA, Werner C, Zannelli RM, Levine B, Smith ML. Screening postmortem blood and tissues for nine classes of drugs of abuse using automated microplate immunoassay. Forensic Sci Int. 1999; 106(2): 93-102. [CrossRef] [PubMed] [Google Scholar]